https://www.selleckchem.com/products/cx-5461.html
Their work gives further insight into the subtle molecular spectrum of SMARCA4-deficient tumours, and their distinction from ATRT and ECRT with SMARCB1 inactivation. The characterisation of these molecular features is likely to play an important role in the future as we try to establish a clinically meaningful framework for the diagnosis and management of these lesions. This article is protected by copyright. All rights reserved.Low- and middle-income countries carry a high burden of preventable cervical cancer cases and deaths. Because
Like
Comment
Share
